Company filings profile · CIK 0001714899
Denali Therapeutics Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Denali Therapeutics Inc. (DNLI): 11 filings in the last 90 days vs 17 in the prior 90 (filing-velocity cooling ↓ · 0.65×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Nov 4, 2026. Source-linked, daily-refreshed.
Material 8-K events — Denali Therapeutics Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Nov 3, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 28, 2026 | Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 4, 2026 | Item 5.07; Financial Statements and Exhibits | ↗ |
| May 22, 2026 | Regulation FD Disclosure | ↗ |
| May 7, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 3, 2026 | Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | Material Direct Financial Obligation; Regulation FD Disclosure | ↗ |
| Mar 25, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch Denali Therapeutics Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Nov 3, 2026 | 10-Q | 10-Q | ↗ |
| Nov 3, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Sep 9, 2026 | 4 | FORM 4 | ↗ |
| Sep 4, 2026 | 144 | ↗ | |
| Sep 4, 2026 | 4 | FORM 4 | ↗ |
| Sep 3, 2026 | 4 | FORM 4 | ↗ |
| Sep 2, 2026 | 144 | ↗ | |
| Sep 1, 2026 | 144 | ↗ | |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 4 | FORM 4 | ↗ |
| Aug 11, 2026 | 144 | ↗ | |
| Aug 6, 2026 | 10-Q | 10-Q | ↗ |
| Aug 6, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 28, 2026 | 8-K | Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
| Jul 8, 2026 | SCHEDULE 13G/A | ↗ | |
| Jun 18, 2026 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | FORM 4 | ↗ |
| Jun 5, 2026 | 4 | 4 | ↗ |
| Jun 4, 2026 | 8-K | Item 5.07; Financial Statements and Exhibits | ↗ |
| May 22, 2026 | 8-K | Regulation FD Disclosure | ↗ |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 7, 2026 | 10-Q | 10-Q | ↗ |
| May 7, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Apr 21, 2026 | 3/A | FORM 3/A | ↗ |
| Apr 21, 2026 | DEFA14A | DEFA14A ADDITIONAL MATERIALS | ↗ |
| Apr 21, 2026 | ARS | ARS | ↗ |
| Apr 21, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 20, 2026 | 3 | FORM 3 | ↗ |
| Apr 3, 2026 | 8-K | Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | 8-K | Material Direct Financial Obligation; Regulation FD Disclosure | ↗ |
| Mar 26, 2026 | SCHEDULE 13G/A | ↗ | |
| Mar 25, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |